Barry Shin serves as the Chief Financial Officer at COMPASS THERAPEUTICS, where he plays a pivotal role in steering the financial strategy and operations of the company. With over two decades of experience in financial management within the biotechnology and pharmaceuticals sectors, Barry has cultivated a reputation for his strategic acumen and leadership. Prior to joining COMPASS THERAPEUTICS, he held significant positions at several prominent biotech firms, including a tenure as Vice President of Finance at Genentech, where he was instrumental in overseeing financial planning and analysis that contributed to the company's robust growth. At COMPASS THERAPEUTICS, Barry Shin has been instrumental in driving the company's financial health and strategic initiatives. Under his leadership, the company has successfully navigated multiple rounds of funding, securing investments that have enabled the expansion of their research and development programs. His expertise in financial strategy has been crucial in optimizing resource allocation, ensuring that COMPASS THERAPEUTICS remains at the forefront of innovation in therapeutic solutions. Barry's achievements extend beyond the financial realm; he has also been a key figure in fostering a culture of transparency and accountability within the organization, which has been vital for its sustained success and growth.